✦ LIBER ✦

LIPOSOMAL DAUNORUBICIN OVERCOMES DRUG RESISTANCE IN HUMAN BREAST, OVARIAN AND LUNG CARCINOMA CELLS

✍ Scribed by Sadava, David; Coleman, Aaron; Kane, Susan E.

Book ID: 118742497
Publisher: Informa plc
Year: 2002
Tongue: English
Weight: 189 KB
Volume: 12
Category: Article
ISSN: 0898-2104
DOI: 10.1081/LPR-120016196

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transferrin overcomes drug resistance to

Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells

✍ David Sadava; Tiphanie Phillips; Cindy Lin; Susan E Kane 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Taxol-oligoarginine conjugates overcome

Taxol-oligoarginine conjugates overcome drug resistance in-vitro in human ovarian carcinoma

✍ Paul A. Wender; Wesley C. Galliher; Neelima M. Bhat; Thomas H. Pillow; Marcia M. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 539 KB

Glucose uptake inhibitor sensitizes canc

Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia

✍ Xianhua Cao; Lanyan Fang; Seth Gibbs; Ying Huang; Zunyan Dai; Ping Wen; Xincheng 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 632 KB

Silibinin reverses drug resistance in hu

Silibinin reverses drug resistance in human small-cell lung carcinoma cells

✍ Sadava, David; Kane, Susan E. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 626 KB

Multifactorial drug resistance in an adr

Multifactorial drug resistance in an adriamycin-resistant human small cell lung cancer carcinoma cell line

📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Contribution of drug transport and reduc

Contribution of drug transport and reductases to daunorubicin resistance in human myelocytic cells

✍ Geetha Vasanthakumar; Nahed K. Ahmed 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 662 KB

We developed three daunorubicin (D1)-resistant sublines (ML1/I, II, III) from the human myelocytic cell line (ML1). These sublines were 28-, 70- and 162-fold more resistant than sensitive (ML1/S) cells to the cytotoxicity of D1 and were cross-resistant to adriamycin, epiadriamycin, actinomycin D, VP